Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
SARS-CoV-2 ORF3a | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF3a | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF3a | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF7a | polyclonal | Goat | SARS coronavirus (SARS-CoV-2) | unconjugated | 300 µg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF7a | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF7a | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF7a | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 ORF7a | polyclonal | Rabbit | SARS coronavirus (SARS-CoV-2) | unconjugated | 0.1 mg | n/a |
ANTIBODIES-ONLINE GmbH |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | plasma | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | plasma | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | serum | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | polyclonal | Human | n/a | serum | n/a | n/a |
ANTIBODY SYSTEMS INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Recombinant Human | Severe acute respiratory syndrome coronavirus 2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2 | monoclonal | Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |